# Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct

> **NCT05008588** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **PT. Prodia Stem Cell Indonesia** · enrollment: 15 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **BIOLOGICAL:** Conditioned Medium
- **BIOLOGICAL:** Umbilical Cord Mesenchymal Stem Cells
- **PROCEDURE:** Neurologic and Neutrophic Drugs

## Key facts

- **NCT ID:** NCT05008588
- **Lead sponsor:** PT. Prodia Stem Cell Indonesia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-30
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05008588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05008588, "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05008588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*